Group One Trading
ORIC icon

Group One Trading’s Oric Pharmaceuticals ORIC Stock Holding History

Group One Trading’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-700
Closed -$3.91K – 8460
2025
Q1 		$3.91K Buy
+700
New +$6.12K ﹤0.01% 6744
2024
Q4 		– Sell
-5,100
Closed -$52.3K – 7771
2024
Q3 		$52.3K Buy
5,100
+100
+2% +$989 ﹤0.01% 4632
2024
Q2 		$35.4K Hold
5,000
– – ﹤0.01% 4784
2024
Q1 		$68.8K Buy
+5,000
New +$59.4K ﹤0.01% 4443
2023
Q4 		– Sell
-6,600
Closed -$39.9K – 7968
2023
Q3 		$39.9K Buy
6,600
+6,200
+1,550% +$50.8K ﹤0.01% 5309
2023
Q2 		$3.1K Buy
+400
New +$2.27K ﹤0.01% 6931
2023
Q1 		– Sell
-11,800
Closed -$69.5K – 7735
2022
Q4 		$69.5K Buy
+11,800
New +$39.8K ﹤0.01% 4755
2022
Q3 		– Sell
-200
Closed -$1K – 8041
2022
Q2 		$1K Hold
200
– – ﹤0.01% 7597
2022
Q1 		$1K Buy
+200
New +$1.8K ﹤0.01% 7855

Other funds holding ORIC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Group One Trading's ORIC Position: Q3 2026 in Review

Group One Trading increased its Oric Pharmaceuticals (ORIC) stake by 17% in Q3 2026, buying an estimated $51.3K and bringing the position to 28,280 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Group One Trading first reported a position in ORIC in Q2 2022 and has held it in 9 quarters since. 124 funds tracked by Wall St. Rank hold ORIC as of Q3 2026.

  • Group One Trading held 28,280 shares of Oric Pharmaceuticals worth $381K as of Q3 2026.
  • Group One Trading bought 4,118 Oric Pharmaceuticals shares in Q3 2026, an estimated $51.3K.
  • Oric Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #3652 holding.
  • Group One Trading first reported a position in Oric Pharmaceuticals in Q2 2022 and has held it in 9 quarters since.
  • 124 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.